GLP-1 analog modulates appetite, taste preference, gut hormones, and regional body fat Stores in Adults with obesity
PlexusDx helps clarify the regulatory foundation, cost structures, and how individual genetic predispositions in peptide pathways may inform which formulation and delivery method best aligns with clinical goals and personal needs
Many users notice diminishing effects after 3 to 5 months of continuous use due to receptor desensitization
Most patients experience weight regain and worsening blood sugar control within weeks to months after stopping tirzepatide
Clin J Pain 2008;24(8):731-733
Similarly, TZDs are as effective as GLP-1RAs in HbA 1C reduction, have fewer GI effects and may have a lower hypoglycaemia risk, but can cause weight gain